Active Cells, Biochemistry & Physiology Genetics & Molecular Biology

Structural and functional characterisation of zDHHC S-Acyltransferases and their complexes with nanobodies, auxilliary proteins, co-factors and substrates

In plain English

AI plain-English summary

A family of 23 human enzymes attaches and removes greasy lipid tags to control whether proteins are active, where they go, and how long they last. When these enzymes—called zDHHCs—malfunction, the tagging process goes wrong, and this has been linked to cancers, heart disease, and neurological disorders. Despite their importance, no one has yet seen the full three-dimensional structure of any zDHHC enzyme bound to the protein it modifies. Researchers also do not understand how a handful of helper proteins switch these enzymes on. This project will use advanced electron microscopy and biochemical methods to determine the atomic-scale architecture of human zDHHC enzymes in complex with their helper proteins and target substrates. By revealing exactly how these enzymes recognise and modify their diverse protein targets, the work could provide the molecular blueprint needed to design drugs that correct faulty S-acylation. Such drugs would be a new class of therapeutics for diseases where current treatments fall short. This is fundamental science—it will not produce a drug tomorrow. But understanding the structural mechanics of a regulatory system that touches hundreds of proteins is the necessary first step toward exploiting it clinically.

View original technical description
Protein S-acylation, commonly known as S-palmitoylation, is a reversible lipid post-translational modification (PTM) catalysed by a family of 23 DHHC domain- containing proteins. This modification regulates protein stability, activity, membrane association, and localisation. Palmitoylation targets many important proteins, including G proteins, ion channels, membrane receptors, and signalling proteins. Consequently, its dysregulation has been linked to cancers, as well as cardiovascular and neurological disorders. Although most zDHHC enzymes function autonomously, a subset has been found to interact with accessory proteins to cause activation, although their precise regulatory roles remain unclear. Furthermore, no full-length enzyme–substrate complexes has yet been structurally characterised, limiting our understanding of how substrate specificity and recognition is achieved by zDHHC enzymes. I aim to unravel the molecular mechanisms by which accessory proteins regulate zDHHC function and to decipher how zDHHC enzymes recognise and interact with their diverse substrates, using structural biology approaches. I will combine biochemical and structural analyses, including specialised electron microscopy techniques, to: • Determine the architecture of human zDHHCs and their complexes with accessory proteins and substrates • Elucidate mechanisms of substrate recognition and specificity by zDHHCs This work could provide the molecular basis for exploiting S-acylation as a future drug target with industrial, clinical, and societal impact.

View the original record at the funder ↗

Researchers

Laura Bartková (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

S-Acylation of transmembrane proteins in the early secretory pathway
Chemical biology of protein S-acylation
Investigating the function and substrate interaction network of ABHD16A, a novel regulator of protein S-acylation
Fatty Acid Specificity in the DHHC Family of S-Acyltransferases: From Mechanisms to Functional Outcomes
A chemical biology approach to interrogate the zDHHC enzymes

Original classification

PhD Studentship (Basic)

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.